Ken Griffin Cumberland Pharmaceuticals Inc Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 24,200 shares of CPIX stock, worth $30,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,200
Previous 38,100
36.48%
Holding current value
$30,250
Previous $64,000
42.19%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CPIX
# of Institutions
25Shares Held
2MCall Options Held
24.2KPut Options Held
200-
Jim Simons Renaissance Technologies LLC | New York, Ny538KShares$672,7030.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA374KShares$467,8130.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX304KShares$380,1360.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX287KShares$358,3180.01% of portfolio
-
Acadian Asset Management LLC Boston, MA188KShares$235,2050.0% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $18.3M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...